Article Sidebar

Submitted
December 13, 2018
Accepted
February 27, 2020
Published
April 30, 2020
Download
PDF (Bahasa Indonesia) (Bahasa Indonesia) (Bahasa Indonesia)
Statistic
Read Counter : 745 Download : 605

Main Article Content

Abstract

Background: Reports about the resistance of antimalarial drugs demand exploration and development of new drugs. Indonesia's vast maritime area and abundance of mangrove forests have the potential for the development and discovery of active anti-cancer substances, antibiotics and antiplasmodial. Studies on the potential of new drugs from this sector are still limited.
Objective: The purpose of this study was to see the potential of Actinomycetes genus Streptomyces sp. as an antiplasmodial in the Hamadi Coast of Papua.
Methods: Retrieval of mangrove soil sediments to isolate Streptomyces was located in the Hamadi-Jayapura mangrove forest. Selective isolation was conducted by SCA (Starch Casein Agar) selective media. Identification of Streptomyces sp was examined microscopically through observation of colony morphology and gram staining. The results of isolation of Streptomyces were then fermented on FM3 media until finally secondary metabolite extract of Streptomyces was obtained. The secondary metabolite extract of Streptomyces was tested for its inhibition on the development of Plasmodium falciparum.
Result: Analysis of inhibition of the secondary metabolite extract of Streptomyces sp on the development of Plasmodium falciparum showed good results because the extract of Streptomyces sp with a concentration of 100 µg/mL could suppress average growth values of Plasmodium falciparum to only 0.66% with an average inhibitory value of 95.20%. This value followed levels of extract concentration by the lowest concentration of 0.01 µg/mL, the average value of Plasmodium falciparum growth which increased to 10.89% with an average inhibition value of 20.83%. IC50 analysis of Plasmodium falciparum in culture for 48 hours was 0.12 µg/mL, and this value was very good because a test of substance has very good inhibitory activity when the IC50 value is = 10 µg/mL.
Conclusion: Streptomyces’ secondary metabolite extract from mangrove sediments showed a very good ability to inhibit the growth of Plasmodium falciparum so that it could have potential as a source of antiplasmodial.

Keywords

Antiplasmodium Actinomycetes Streptomyces Mangrove

Article Details

License

Authors who publish in the Jurnal Kedokteran dan Kesehatan Indonesia agree to the following terms:

  1. Authors retain copyright and grant Jurnal Kedokteran dan Kesehatan Indonesia right of first publication with the work simultaneously licensed under a Creative Commons Attribution Licence that allows others to adapt (remix, transform, and build) upon the work non-commercially with an acknowledgement of the work's authorship and initial publication in Jurnal Kedokteran dan Kesehatan Indonesia.
  2. Authors are permitted to share (copy and redistribute) the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in Jurnal Kedokteran dan Kesehatan Indonesia.
How to Cite
Sandy, S., & Sasto, I. H. S. (2020). Inhibition of secondary metabolite extract of Streptomyces sp. on Plasmodium falciparum in vitro: A study of soil sediment of Papua’s Hamadi mangrove forest. JKKI : Jurnal Kedokteran Dan Kesehatan Indonesia, 11(1), 34–43. https://doi.org/10.20885/JKKI.Vol11.Iss1.art6
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. McCarthy PJ, Roberts BF, Carbonell A, Roberts J, Wright AE, Chakrabarti D. Marine microbiome as a source of antimalarials. Tropical Medicine and Infectious Disease. 2019;4(3).
  2. Jadon R, Singh V, Chaudhary HS. Update on bioactive molecules of actinomycetes. Biosciences Biotechnology Research Asia. 2014;11(2):705–14.
  3. Sharma S, Fulke AB, Chaubey A. Bioprospection of marine actinomycetes: recent advances, challenges and future perspectives. Acta Oceanologica Sinica. 2019;38(6).
  4. Dahari DE, Mohamad Salleh R, Mahmud F, Ping Chin L, Embi N, Mohd Sidek H. Anti-malarial activities of two soil actinomycete isolates from sabah via inhibition of glycogen synthase kinase 3ß. Tropical Life Sciences Research. 2016;27(2):53–71.
  5. Phongsopitanun W, Suwanborirux K, Tanasupawat S. Distribution and antimicrobial activity of Thai marine actinomycetes. Journal of Applied Pharmaceutical Science. 2019;9(2):129–34.
  6. Dita SF, Budiarti S, Lestari Y. Sponge-Associated Actinobacteria: Morphological Character and Antibacterial Activity against Pathogenic Bacteria. Jurnal Sumberdaya Hayati. 2018;3(1).
  7. Subramani R, Sipkema D. Marine rare actinomycetes: A promising source of structurally diverse and unique novel natural products. Marine Drugs. 2019;17(5).
  8. Dhakal D, Pokhrel AR, Shrestha B, Sohng JK. Marine rare actinobacteria: Isolation, characterization, and strategies for harnessing bioactive compounds. Frontiers in Microbiology. 2017;8.
  9. Zin NM, Baba MS, Zainal-Abidin AH, Latip J, Mazlan NW, Edrada-Ebel R. Gancidin W, a potential low-toxicity antimalarial agent isolated from an endophytic Streptomyces SUK10. Drug Design, Development and Therapy. 2017 Feb;Volume11:351–63.
  10. Pang X, Zhao J, Fang X, Liu H, Zhang Y, Cen S, et al. Surfactin derivatives from Micromonospora sp. CPCC 202787 and their anti-HIV activities. Journal of Antibiotics. 2017;70(1):105–8.
  11. Mayer AMS, Rodríguez AD, Taglialatela-Scafati O, Fusetani N. Marine pharmacology in 2012–2013: Marine compounds with antibacterial, antidiabetic, antifungal, anti-inflammatory, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous systems, and other miscellaneous mechanisms of action. Marine Drugs. 2017;15(9).
  12. Njenga P, Mwaura, JM W, EM G. Methods of Isolating Actinomycetes from the Soils of Menengai Crater in Kenya. Archives of Clinical Microbiology. 2017;08(03).
  13. Mohamed H, Zohra F, Mohamed H, Miloud B, Garcia-Arenzana JM, Veloso A, et al. Isolation and Characterization of Actinobacteria from Algerian Sahara Soils with Antimicrobial Activities. International journal of molecular and cellular medicine. 2017;6(2):109–20.
  14. HooiLeng S, Mutalib N-SA, WaiFong Y, KokGan C, BeyHing G, LearnHan L. Evaluation of antioxidative and cytotoxic activities of Streptomyces pluripotens MUSC 137 isolated from mangrove soil in Malaysia. Frontiers in Microbiology. 2015;6(December):1398.
  15. Hong K, Gao AH, Xie QY, Gao H, Zhuang L, Lin HP, et al. Actinomycetes for marine drug discovery isolated from mangrove soils and plants in China. Marine Drugs. 2009;7(1):24–44.
  16. Srividya AR, Katta R, Vishnuvarthan VJ. Isolation , identification , bioprocessing and characterization of secondary metabolites for its antimicrobial and genotoxicity from the soil screened microorganism. International Journal of Current Microbiology and Apllied Sciences. 2014;3(4):694–708.
  17. Fitri LE, Alkarimah A, Cahyono AW, Lady WN, Endharti AT, Nugraha RYB. Effect of metabolite extract of Streptomyces hygroscopicus subsp. hygroscopicus on Plasmodium falciparum 3D7 in vitro. Iranian Journal of Parasitology. 2019;14(3):444–52.
  18. Salaria N, Sharma S, Sharma S. Isolation and Screening of Actinomycetes from Soil Sample of Dal Lake (Kashmir) Against Selected Pathogens. International Journal of Advanced Engineering Science and Technological Research. 2016;2(1):51–4.
  19. Sweetline C, Usha R. Evaluation of the antimalarial potential of streptomyces sp. Asian Journal of Pharmaceutical and Clinical Research. 2018;11(2):354–8.
  20. Lam KS. Discovery of novel metabolites from marine actinomycetes. Current Opinion in Microbiology. 2006;9(3):245–51.
  21. Sunaryanto R. Marine Actinomycetes screening of Banten West Coast and their antibiotics purification. Biodiversitas, Journal of Biological Diversity. 2010 Oct 1;11(4):176–81.
  22. Maskey RP, Helmke E, Fiebig HH, Laatsch H. Parimycin: Isolation and structure elucidation of a novel cytotoxic 2,3-dihydroquinizarin analogue of ?-indomycinone from a marine Streptomycete isolate. Journal of Antibiotics. 2002;55(12):1031–5.
  23. Bavya M, Mohanapriya P, Pazhanimurugan R, Balagurunathan R. Potential bioactive compound from marine actinomycetes against biofouling bacteria. Indian Journal of Marine Sciences. 2011;40(4):578–82.
  24. Nimbekar T, Bais YG, Wanjari BE, Timande SP. Isolation of Antibacterial Compound From Marine Soil Actinomycetes. International Journal of Biomedical and Advance Research. 2012;3(3).
  25. Rinidar R, Isa M, Armansyah T. Nilai inhibition concentration (ic50) ekstrak metanol daun sernai (Wedelia biflora) terhadap Plasmodium falciparum yang diinkubasi selama 32 dan 72 jam. Jurnal Medika Veterinaria. 2013;7(1):8–10.
  26. Babuselvam M, Ravikumar S, Abideen S, Mohamed MP, Mohamed HSM. in Vitro Antiplasmodial Activity of Seaweed Associated Actinomycetes Against Plasmodium Falciparum. World Journal of Pharmacy and Pharmaceutical Sciences. 2005;3(2):712–20.
  27. Ahmad SJ, Abdul Rahim MBH, Baharum SN, Baba MS, Zin NM. Discovery of Antimalarial Drugs from Streptomycetes Metabolites Using a Metabolomic Approach. Journal of Tropical Medicine. 2017;2017.
  28. Wafaa Haggag W, Abd El Kreem F, Hoballa E. Marine streptomycetes: Characteristics and their antifungal activities. Research Journal of Pharmaceutical, Biological and Chemical Sciences. 2014;5(5):651–6.
  29. Karthik L, Kumar G, Keswani T, Bhattacharyya A, Sarath Chandar S, Bhaskara Rao K V. Protease inhibitors from marine actinobacteria as a potential source for antimalarial compound. PLoS ONE. 2014;9(3).
  30. Zhang YM, Li HY, Hu C, Sheng HF, Zhang Y, Lin BR, et al. Ergosterols from the culture broth of marine streptomyces anandii H41-59. Marine Drugs. 2016;14(5).
  31. Liang Y, Xie X, Chen L, Yan S, Ye X, Anjum K, et al. Bioactive Polycyclic Quinones from Marine Streptomyces sp. 182SMLY. Marine Drugs. 2016;14(1).